IRMDStockIradimed Corp
Verdicts genuinely change. Free email alert the moment IRMD's does — no target price to set, unlike a price alert.
Near limit Ratio screen, 4 of 7 decided standards passing. AAOIFI, Dow Jones Islamic, MSCI Islamic M-Series, S&P Shariah are within 3 points of their line. If they all crossed, the majority verdict would move from Compliant to Not compliant. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Iradimed Corp (IRMD) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-06). See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →
How the status reached this point
Compliant · status tracked since Nov 17, 2026
No change to IRMD’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 19, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $1.1B as of 2026-11-17. At the 2026-11-20 close it is about $1.0B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 0.0% (0.0% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 6.0% (5.8% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 30.00% | Pass(30.0pp buffer) |
| Interest-bearing investments | 5.83% | 30.00% | Pass(24.2pp buffer) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
Usmani Fail 4 of 5 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass(33.0pp buffer) |
| Interest-bearing investments | 52.27% | 33.00% | Fail(19.3pp over) |
| Non-liquid assets | 36.43% | at least 20.00% | Pass(16.4pp above the floor) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
| Net liquid assets per share | $66.6M | under mkt cap $1.1B | Pass |
MSCI Fail 2 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass(33.3pp buffer) |
| Cash + interest-bearing securities | 52.27% | 33.33% | Fail(18.9pp over) |
| Accounts receivable | 63.57% | 33.33% | Fail(30.2pp over) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
FTSE Fail 2 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass(33.3pp buffer) |
| Cash + interest-bearing securities | 52.27% | 33.33% | Fail(18.9pp over) |
| Accounts receivable | 63.57% | 50.00% | Fail(13.6pp over) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass(33.0pp buffer) |
| Cash + interest-bearing securities | 6.30% | 33.00% | Pass(26.7pp buffer) |
| Accounts receivable | 1.36% | 33.00% | Pass(31.6pp buffer) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.00% | Pass(33.0pp buffer) |
| Cash + interest-bearing securities | 7.36% | 49.00% | Pass(41.6pp buffer) |
| Accounts receivable | 1.59% | 49.00% | Pass(47.4pp buffer) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 0.00% | 33.33% | Pass(33.3pp buffer) |
| Cash + interest-bearing securities | 7.36% | 33.33% | Pass(26.0pp buffer) |
| Accounts receivable | 8.95% | 49.00% | Pass(40.1pp buffer) |
| Non-permissible income | 2.40% | 5.00% | Pass(2.6pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from IRMD's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $83.8M | 2025-12-31 | Revenues |
| Interest-bearing debtShort and long-term borrowings | $0 | 2026-09-30 | no debt tag reported in 3+ years (treated as $0) |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $63.3M | 2026-09-30 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $121.1M | 2026-09-30 | Assets |
| Market capDenominator for AAOIFI | $1.1B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $828.8M | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $967.5M | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $2.0M | 2025-12-31 | InvestmentIncomeInterest |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-10-30, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-03-06, period ended 2025-12-31. Screened 2026-11-17.
-
Total assets$121.1M
Assets· period ended 2026-09-30 · 10-Q filed 2026-10-30 -
Interest-bearing debt$0
no debt tag reported in 3+ years (treated as $0)· balance sheet as of 2026-09-30 · no filing link for this figure -
Cash and interest-bearing securities$63.3M
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· period ended 2026-09-30 · 10-Q filed 2026-10-30 -
Receivables$13.7M
AccountsReceivableNetCurrent· period ended 2026-09-30 · 10-Q filed 2026-10-30 -
Revenue$83.8M
Revenues· period ended 2025-12-31 · 10-K filed 2026-03-06 -
Interest income (non-permissible)$2.0M
InvestmentIncomeInterest· period ended 2025-12-31 · 10-K filed 2026-03-06 -
Market cap$1.1BMarket quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-17 · not a filing figure, so no link
5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.
What changed, and when
Verdict history for IRMD. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for IRMD has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
Not disclosed by segment: the latest 10-K (fiscal year ended 2025-12-31) does not tag its revenue by product, service or business segment in its XBRL, so there is no split to show. None is estimated.
Source: 10-K filed 2026-03-06 (accession 0001104659-26-024691), read from its XBRL on SEC EDGAR.
What would change the status
The headline verdict is the majority of the decided ratio standards — 4 pass and 3 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-17.
Within 3 points of the line
- AAOIFI non permissible income ratio: 2.6pp buffer
- Dow Jones Islamic non permissible income ratio: 2.6pp buffer
- S&P Shariah non permissible income ratio: 2.6pp buffer
- MSCI Islamic M-Series non permissible income ratio: 2.6pp buffer
AAOIFI, Dow Jones Islamic, MSCI Islamic M-Series, S&P Shariah are within 3 points of their line. If they all crossed, the majority verdict would move from Compliant to Not compliant.
The ratios that move with the share price
AAOIFI's debt ratio (0.0% against a 30% line) would only fail if the market cap fell by 100%, to $0. At the 2026-11-20 close it would read 0.0%.
AAOIFI's investments ratio (5.8% against a 30% line) would only fail if the market cap fell by 81%, to $211.0M. At the 2026-11-20 close it would read 6.0%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Medical Devices listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| ABTAbbott Laboratories | $201.9B | — |
| SYKStryker Corp. | $125.7B | — |
| MDTMedtronic Plc | $117.8B | — |
| BSXBoston Scientific Corp. | $71.0B | — |
| EWEdwards Lifesciences Corp | $52.2B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold IRMD
8 of the 273 funds whose filed holdings we currently hold own IRMD shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns IRMD.
You may already own itWidely held U.S. index funds. If you own one, you own IRMD through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | IRMD in fund | Fund compliant by weight |
|---|---|---|
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.00% | 54% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.00% | 54% |
| SCHB Schwab U.S. Broad Market ETF | 0.00% | 53% |
| Fund | IRMD in fund | Fund compliant by weight |
|---|---|---|
| IPSIX VOYA INDEX PLUS SMALLCAP PORTFOLIO | 0.20% | 38% |
| DFSCX U.S. MICRO CAP PORTFOLIO | 0.05% | 33% |
| PSIJX SmallCap Growth Fund I | 0.00% | 54% |
| JAFVX Strategic Equity Allocation Trust | 0.00% | 48% |
| FCTDX Strategic Advisers Fidelity U.S. Total Stock Fund | 0.00% | not computed |
Sorted by IRMD’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names IRMD once, so a bond is not counted as the shares. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Peter Brown | Renaissance Technologies | $30M | 0.0% | 2026-09-30 |
| Israel Englander | Millennium Management | $6M | 0.0% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $4M | 0.0% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $3M | 0.0% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $2M | 0.0% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 42.80 | NEUTRAL |
| Stochastic %K (14) | 29.84 | NEUTRAL |
| CCI (20) | -77.66 | NEUTRAL |
| Williams %R (14) | -70.16 | NEUTRAL |
| MACD (12,26,9) | -0.32 | SELL |
| ROC (10) | -4.75 | SELL |
| Momentum (10) | -4.09 | SELL |
| EMA (10) | 83.53 | SELL |
| SMA (10) | 84.39 | SELL |
| EMA (20) | 84.23 | SELL |
| SMA (20) | 83.89 | SELL |
| EMA (30) | 84.64 | SELL |
| SMA (30) | 85.32 | SELL |
| EMA (50) | 85.35 | SELL |
| SMA (50) | 85.09 | SELL |
| EMA (100) | 87.10 | SELL |
| SMA (100) | 87.91 | SELL |
| EMA (200) | 90.22 | SELL |
| SMA (200) | 90.96 | SELL |
About Iradimed Corp
Healthcare · Medical Devices
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
Background via Yahoo Finance — informational, not part of the verdict.
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
Scores: 1 bullish / 1 bearish
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 63 |
| ⏰ 4H | BEARISH | 23 |
| 🕐 1H | BEARISH | 92 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NEUTRAL 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.